PFIZER Q1 REVENUES Pfizer reported first-quarter 2026 revenues of $14.5 billion, up $736 million, or 5%, compared with the same period last year
Within this framework: HRT supports neural bioenergetics and mitochondrial stability, helping sustain adequate energy supply GLP-1 therapies reduce systemic and central inflammatory stress, improving the environment in which neurons function Rather than acting in isolation, these therapies may operate synergistically to stabilize both energy production and stress response systems within the brain
Other common side effects include: Dizziness and lightheadedness, particularly during the first few weeks Fatigue and low energy , often related to reduced caloric intake Headaches , which typically resolve within the first month Sulfur burps , a distinctive and common complaint Diarrhea , which usually resolves as the body adjusts Injection site reactions including redness and mild swelling Less common but important considerations Some patients experience hair loss on GLP-1 medications
Referral to gastroenterology is appropriate when patients experience persistent symptoms despite conservative management, require objective gastroparesis diagnosis, or need specialized nutritional support
: L- ,
Compounded drugs can be important for overcoming shortages or meeting unique patient needs but compounders should not try to compound drugs in a way that circumvents FDAs approval process. The 30 companies that received warning letters are mostly small to midsize, digital telehealth providers that moved quickly to meet surging consumer demand for GLP-1 weight loss therapies when manufacturing capacity constraints limited supplies
